Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA greenlights first non-opioid treatment for severe pain in 20 years
Journavax was shown in clinical trials to be safe and effective, with no addictive potential.
PCI before TAVR linked to better outcomes than performing both at once
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Swedish total artificial heart tech granted FDA’s humanitarian use designation
Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.
New findings prompt experts to call for routine brain imaging of certain breast cancer patients
New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed.
Medical device company raises $36M for emitter-free IVL platform
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.

Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology.

Risk of death increases when TEER patients present with hypertrophic cardiomyopathy

A team of Cleveland Clinic researchers tracked data from nearly 23,000 patients, sharing their findings in the American Journal of Cardiology.

Pre-procedure CT imaging benefits LAA occlusion in Henry Ford study

There is not agreement among the top structural heart experts if CT is required for left atrial appendage occlusion (LAAO), but a Henry Ford Hospital study shows it can improve outcomes.

Cardiac surgeons gaining procedural volume despite TAVR making up 84% of cases

A decade ago, when TAVR was first cleared by the FDA, surgeons had concern about losing business. But unexpectedly, TAVR has helped also gain heart surgery cases.

The Harmony pulmonary valve was among the devices involved with the FDA Breakthrough Device Designation program that gained more rapid market clearance. The FDA graph shows cardiovascular devices leading the types of devices involved in the program.

Cardiovascular devices lead FDA Breakthrough Device Designation program

The FDA said cardiovascular devices make up the largest number of technologies accepted into the Breakthrough Devices Program, and several are on the list of the first 50 in the program to gain market clearance.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

VIDEO: How to build a collaborative heart team in structural heart

Brijeshwar Maini, MD, structural heart cardiologist, national and Florida medical director of cardiology, Tenant Health, explains what hospitals need to build a structural heart program and develop a heart-team care collaboration approach.

This latest shortage involves dobutamine, an injectable medication often prescribed for advanced heart failure and cardiogenic shock. It is also a central component of dobutamine stress echocardiography (DSE), a test used to evaluate patients with severe aortic stenosis.

A new supply issue hits cardiology: 5 recommendations for cardiologists during the dobutamine shortage

The shortage could lead to significant issues for cardiologists. The American College of Cardiology provided some words of wisdom on the ongoing issue.

Cardiologists sound the alarm as ‘staggering’ new data suggest CVD rates in the U.S. will rise dramatically

New data from the CDC and U.S. Census Bureau show just how bad CVD rates could get in the next few decades. Specialists agree that a lot of work is needed to help keep these estimates from becoming a reality.

Radiation therapy more likely to cause second primary cancer in prostate cancer patients

The authors stated that their results should not deter providers from offering their patients radiotherapy treatment but rather encourage in-depth discussions and shared decisions pertaining to the best options.

Clinical

FDA greenlights first non-opioid treatment for severe pain in 20 years

PCI before TAVR linked to better outcomes than performing both at once

Swedish total artificial heart tech granted FDA’s humanitarian use designation

New findings prompt experts to call for routine brain imaging of certain breast cancer patients

Medical device company raises $36M for emitter-free IVL platform